BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27100199)

  • 1. Familial Alzheimer's Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds.
    Veugelen S; Saito T; Saido TC; Chávez-Gutiérrez L; De Strooper B
    Neuron; 2016 Apr; 90(2):410-6. PubMed ID: 27100199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in
    Montenegro P; Chen P; Kang J; Lee SH; Leone S; Shen J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2306714120. PubMed ID: 37816062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knock-in rats with homozygous
    Tambini MD; D'Adamio L
    J Biol Chem; 2020 May; 295(21):7442-7451. PubMed ID: 32265300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization.
    Zhou R; Yang G; Shi Y
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12731-12736. PubMed ID: 29078389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain.
    Xia D; Kelleher RJ; Shen J
    Neuron; 2016 Apr; 90(2):417-22. PubMed ID: 27100200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.
    Page RM; Baumann K; Tomioka M; Pérez-Revuelta BI; Fukumori A; Jacobsen H; Flohr A; Luebbers T; Ozmen L; Steiner H; Haass C
    J Biol Chem; 2008 Jan; 283(2):677-83. PubMed ID: 17962197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative changes in human γ-secretase underlie familial Alzheimer's disease.
    Szaruga M; Veugelen S; Benurwar M; Lismont S; Sepulveda-Falla D; Lleo A; Ryan NS; Lashley T; Fox NC; Murayama S; Gijsen H; De Strooper B; Chávez-Gutiérrez L
    J Exp Med; 2015 Nov; 212(12):2003-13. PubMed ID: 26481686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ43 levels determine the onset of pathological amyloid deposition.
    Tambini MD; Yin T; Yesiltepe M; Breuillaud L; Zehntner SP; d'Abramo C; Giliberto L; D'Adamio L
    J Biol Chem; 2023 Jul; 299(7):104868. PubMed ID: 37257821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
    Zhang C; Browne A; Kim DY; Tanzi RE
    Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
    Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
    Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.
    Petit D; Fernández SG; Zoltowska KM; Enzlein T; Ryan NS; O'Connor A; Szaruga M; Hill E; Vandenberghe R; Fox NC; Chávez-Gutiérrez L
    Mol Psychiatry; 2022 Jun; 27(6):2821-2832. PubMed ID: 35365805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Setu JR; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Neurotox Res; 2020 Dec; 38(4):833-849. PubMed ID: 32556937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
    Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
    Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
    Arber C; Toombs J; Lovejoy C; Ryan NS; Paterson RW; Willumsen N; Gkanatsiou E; Portelius E; Blennow K; Heslegrave A; Schott JM; Hardy J; Lashley T; Fox NC; Zetterberg H; Wray S
    Mol Psychiatry; 2020 Nov; 25(11):2919-2931. PubMed ID: 30980041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production.
    Heilig EA; Gutti U; Tai T; Shen J; Kelleher RJ
    J Neurosci; 2013 Jul; 33(28):11606-17. PubMed ID: 23843529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.